
Thursday, May 12, 2022 2:23:42 PM

Liked By
Spread the love. Be the first to like this post!
Recent AUTL News
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 03/20/2023 01:14:19 PM
- Autolus Therapeutics announces resignation of Chief Financial Officer • GlobeNewswire Inc. • 03/14/2023 11:00:00 AM
- Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023 • GlobeNewswire Inc. • 02/15/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 10:24:32 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 05:10:40 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 03:29:38 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 01/23/2023 10:08:34 PM
- Autolus Therapeutics announces Board changes • GlobeNewswire Inc. • 01/20/2023 12:00:00 PM
- Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease • GlobeNewswire Inc. • 01/09/2023 12:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/21/2022 10:21:21 PM
- Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs • GlobeNewswire Inc. • 12/21/2022 09:01:00 PM
- Mizuho Securities Remains a Buy on Autolus Therapeutics (AUTL) • TipRanks • 12/12/2022 08:25:12 PM
- Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022 • GlobeNewswire Inc. • 12/12/2022 03:00:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/12/2022 11:01:18 AM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/12/2022 11:01:09 AM
- Needham Remains a Buy on Autolus Therapeutics (AUTL) • TipRanks • 12/09/2022 02:15:16 PM
- Autolus Tanks After Pricing of Public Offering • TipRanks • 12/09/2022 10:58:04 AM
- Autolus Announces Pricing of Public Offering • GlobeNewswire Inc. • 12/09/2022 02:11:25 AM
- Mizuho Securities Keeps Their Buy Rating on Autolus Therapeutics (AUTL) • TipRanks • 12/08/2022 11:45:09 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/08/2022 09:17:44 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 12/08/2022 09:11:11 PM
- Autolus Announces Proposed Public Offering in the United States • GlobeNewswire Inc. • 12/08/2022 09:03:13 PM
- Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences • GlobeNewswire Inc. • 12/08/2022 09:02:48 PM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM